Lee Financial’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-19
Closed -$4.32K – 535
2023
Q4
$4.32K Buy
19
+11
+138% +$2.31K ﹤0.01% 577
2023
Q3
$1.61K Sell
8
-12
-60% -$2.53K ﹤0.01% 730
2023
Q2
$4.1K Buy
20
+11
+122% +$2.13K ﹤0.01% 538
2023
Q1
$1.84K Sell
9
-227
-96% -$46.7K ﹤0.01% 686
2022
Q4
$47.8K Buy
236
+9
+4% +$1.76K 0.01% 257
2022
Q3
$40K Sell
227
-10
-4% -$2.05K 0.01% 268
2022
Q2
$48K Sell
237
-5
-2% -$1.07K 0.01% 249
2022
Q1
$54K Sell
242
-8
-3% -$1.88K 0.01% 235
2021
Q4
$67K Buy
250
+8
+3% +$1.98K 0.01% 223
2021
Q3
$59K Hold
242
– – 0.01% 211
2021
Q2
$57K Buy
+242
New +$55.1K 0.01% 218

Other funds holding LH

Lee Financial's LH Position: Q1 2024 in Review

Lee Financial sold out of Labcorp (LH) in Q1 2024, closing a stake of 19 shares — an estimated $4.32K sold.

Lee Financial first reported a position in LH in Q2 2021 and held it in 11 quarters. The position peaked at $67K in Q4 2021. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • Lee Financial reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 19 Labcorp shares in Q1 2024, an estimated $4.32K.
  • Lee Financial first reported a position in Labcorp in Q2 2021 and held it in 11 quarters.
  • Lee Financial's Labcorp position peaked at $67K in Q4 2021.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.